From Vision to Reality: US Market Entry and Public Market Pathways

About this session

Entering the US market represents a transformative opportunity for life science companies, offering access to the world’s largest healthcare ecosystem and robust capital markets. This panel, featuring investors and C-suite leaders, will delve into the strategies and pathways for successful US market entry.

Speakers

• 

  Kelly Provost

  Managing Director – Accounting & Reporting Advisory · Stout

  Moderator

• 

  Maha Radhakrishnan

  Executive Partner · Sofinnova Investments

  Panelist

• MV

  Mathias Vinther

  Partner · Forbion

  Panelist

• 

  Janke Dittmer

  General Partner, Head of European HealthTech Investments · Gilde Healthcare

  Panelist

• 

  John Rudy

  Member / Co-chair, Securities & Capital Markets Practice · Mintz

  Panelist

• 

  Magdalena Jonikas

  Partner · JEITO

  Panelist